Besner Morin, Catherine <br/><br/>
Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma.  [electronic resource] 

 -  Journal of cutaneous medicine and surgery  May 2016 
 - 244-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1615-7109 
<br/><br/><label>Standard No.: </label>10.1177/1203475415626686  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lymphoma, T-Cell, Cutaneous--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Nicotinic Acids--administration & dosage<br/>Prospective Studies<br/>Skin Neoplasms--drug therapy<br/>Treatment Outcome<br/>Young Adult